• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer.基于诊所的乳腺癌女性群体中遗传咨询和检测的应用。
Cancer Med. 2022 Sep;11(17):3304-3311. doi: 10.1002/cam4.4684. Epub 2022 Mar 23.
2
Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.减少服务不足的遗传性乳腺癌和卵巢癌风险女性获得遗传咨询的差异。
J Womens Health (Larchmt). 2020 Aug;29(8):1131-1135. doi: 10.1089/jwh.2019.7984. Epub 2019 Nov 27.
3
Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer.早期结直肠癌患者的遗传咨询和检测的转诊、接受和结果。
J Natl Compr Canc Netw. 2023 Nov;21(11):1156-1163.e5. doi: 10.6004/jnccn.2023.7057.
4
Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.种族差异可能通过咨询来减轻乳腺癌基因检测的影响。
Ann Surg Oncol. 2024 Aug;31(8):5197-5204. doi: 10.1245/s10434-024-15434-2. Epub 2024 May 29.
5
Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.乳腺癌女性转诊至遗传学专业人员的国家综合癌症网络指南的遵循模式。
Am J Clin Oncol. 2016 Aug;39(4):363-7. doi: 10.1097/COC.0000000000000073.
6
Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.遵循美国国立综合癌症网络(NCCN)关于转诊至癌症遗传专业人员的指南的模式。
Gynecol Oncol. 2015 Jul;138(1):109-14. doi: 10.1016/j.ygyno.2015.04.029. Epub 2015 Apr 28.
7
Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.改善家族性乳腺癌遗传咨询的转诊流程:两项干预措施的三项随机对照试验结果
Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. doi: 10.3310/hta9030.
8
Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.高危乳腺癌患者对BRCA基因咨询外科转诊信的回忆及反应。
Ann Surg Oncol. 2009 Jul;16(7):1973-81. doi: 10.1245/s10434-009-0479-4. Epub 2009 Apr 30.
9
Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.美国医生中报告的遗传咨询或 BRCA1/2 检测转诊情况:基于案例的研究。
Cancer. 2011 Dec 1;117(23):5334-43. doi: 10.1002/cncr.26166. Epub 2011 Jul 25.
10
Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.高危西班牙裔偏好拉丁裔乳腺癌幸存者的提供者讨论遗传咨询。
Transl Behav Med. 2022 Oct 7;12(9):900-908. doi: 10.1093/tbm/ibac031.

引用本文的文献

1
The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study.主流基因检测途径和社会经济因素对乳腺癌患者接受种系基因检测的影响:全国性GENE-SMART研究结果
Breast Cancer Res. 2025 Jul 14;27(1):129. doi: 10.1186/s13058-025-02081-y.
2
Genetic counseling referral rates and genetic testing outcomes in women with young breast cancer: a 20-year Canadian review.年轻乳腺癌女性的遗传咨询转诊率及基因检测结果:一项为期20年的加拿大回顾性研究
Breast Cancer Res Treat. 2025 Jun;211(2):321-330. doi: 10.1007/s10549-025-07646-1. Epub 2025 Feb 22.
3
Evidence-based advancements in breast cancer genetic counseling: a review.乳腺癌遗传咨询的循证进展:综述
Breast Cancer. 2025 Mar;32(2):258-277. doi: 10.1007/s12282-024-01660-9. Epub 2024 Dec 17.
4
Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling.家族性高胆固醇血症级联检测的创新实施策略:遗传咨询的影响
J Pers Med. 2024 Aug 9;14(8):841. doi: 10.3390/jpm14080841.
5
Impact of barriers and motivators on intention and confidence to undergo hereditary cancer genetic testing.障碍和动机对遗传性癌症基因检测意愿及信心的影响
J Genet Couns. 2025 Feb;34(1):e1926. doi: 10.1002/jgc4.1926. Epub 2024 May 27.
6
Disparities in Breast Cancer Care-How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity.乳腺癌治疗的差异——与预防、诊断和治疗相关的因素如何导致不平等。
Healthcare (Basel). 2024 Feb 12;12(4):462. doi: 10.3390/healthcare12040462.
7
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.聊天机器人人工智能在遗传癌症风险评估和咨询中的应用:系统评价和荟萃分析。
JCO Clin Cancer Inform. 2023 Sep;7:e2300123. doi: 10.1200/CCI.23.00123.
8
Psychosocial factors impacting barriers and motivators to cancer genetic testing.影响癌症基因检测障碍和促进因素的心理社会因素。
Cancer Med. 2023 Apr;12(8):9945-9955. doi: 10.1002/cam4.5709. Epub 2023 Feb 19.

本文引用的文献

1
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.基于人群的乳腺癌患者和卵巢癌患者队列中的基因检测和结果。
J Clin Oncol. 2019 May 20;37(15):1305-1315. doi: 10.1200/JCO.18.01854. Epub 2019 Apr 9.
2
Disparities in genetic services utilization in a random sample of young breast cancer survivors.随机抽样的年轻乳腺癌幸存者中基因检测服务利用的差异。
Genet Med. 2019 Jun;21(6):1363-1370. doi: 10.1038/s41436-018-0349-1. Epub 2018 Nov 2.
3
Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.尽管普遍开展了结直肠癌筛查,但在不同种族和民族的患者中,遗传检测的转诊率仍然较低。
Clin Gastroenterol Hepatol. 2018 Dec;16(12):1911-1918.e2. doi: 10.1016/j.cgh.2018.08.038. Epub 2018 Aug 18.
4
Disparities in genetics assessment for women with ovarian cancer: Can we do better?卵巢癌女性遗传评估中的差异:我们能否做得更好?
Gynecol Oncol. 2018 Apr;149(1):84-88. doi: 10.1016/j.ygyno.2017.10.034.
5
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.有乳腺癌或卵巢癌病史女性的基因检测全国估计数。
J Clin Oncol. 2017 Dec 1;35(34):3800-3806. doi: 10.1200/JCO.2017.73.6314. Epub 2017 Aug 18.
6
Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK.基于英国家族性高胆固醇血症服务机构的数据,对家族性高胆固醇血症的级联检测的成本效益进行评估。
Eur Heart J. 2017 Jun 14;38(23):1832-1839. doi: 10.1093/eurheartj/ehx111.
7
Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.基于人群的年轻乳腺癌幸存者样本中BRCA检测与癌症风险管理的种族差异。
Cancer. 2017 Jul 1;123(13):2497-2505. doi: 10.1002/cncr.30621. Epub 2017 Feb 9.
8
Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.对基因咨询后患者不进行BRCA基因检测原因的大型前瞻性分析。
J Genet Couns. 2017 Aug;26(4):859-865. doi: 10.1007/s10897-016-0064-5. Epub 2017 Jan 16.
9
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.医疗保健隔离、医生建议与乳腺癌女性BRCA1/2检测中的种族差异
J Clin Oncol. 2016 Aug 1;34(22):2610-8. doi: 10.1200/JCO.2015.66.0019. Epub 2016 May 9.
10
Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors.非裔美国年轻乳腺癌幸存者对癌症遗传学服务的使用情况。
Am J Prev Med. 2016 Oct;51(4):427-36. doi: 10.1016/j.amepre.2016.03.016. Epub 2016 Apr 23.

基于诊所的乳腺癌女性群体中遗传咨询和检测的应用。

Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer.

机构信息

Wayne State University School of Medicine, Detroit, Michigan, USA.

Population Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA.

出版信息

Cancer Med. 2022 Sep;11(17):3304-3311. doi: 10.1002/cam4.4684. Epub 2022 Mar 23.

DOI:10.1002/cam4.4684
PMID:35322585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9468430/
Abstract

BACKGROUND

The study was conducted to evaluate racial differences in referral and uptake of genetic counseling (GC) in a clinic-based population of women with breast cancer.

METHODS

Medical records of 150 breast cancer patients at the Karmanos Cancer Institute were reviewed to determine eligibility for GC according to National Comprehensive Cancer Network guidelines, GC referral rates, and appointment completion rates. Logistic regression was used to assess the relationship between demographic and clinical factors and GC eligibility and referral.

RESULTS

The mean age at diagnosis was 57.1 (SD 12.6) and 66% of the women were Black. There were 91 women (60.7%) eligible for GC and of those, 54 (61.4%) were referred. After multivariable analyses, factors associated with reduced eligibility were older age at diagnosis (OR = 0.91, 95% CI [0.87,0.95]) and Black race (OR = 0.37, 95% CI [0.15, 0.96]). After additional multivariable analysis, eligibility was associated with an increased likelihood of referral (OR = 5.97, 95% CI [2.29, 15.56]), however, Medicare versus private insurance was associated with a lower likelihood for referral (OR = 0.32, 95% CI [0.12-0.80]. Of those referred, 49 (76.6%) completed an appointment, and 47 had genetic testing. Women with Medicare were also less likely to complete an appointment. Race had no impact on referral or appointment completion.

CONCLUSIONS

There were no racial differences in GC referral or appointment completion in a clinic-based sample of women with breast cancer. Further interventions are needed to promote increased referral and appointment completion for women with breast cancer who are eligible for GC.

摘要

背景

本研究旨在评估基于诊所的乳腺癌患者群体中,遗传咨询(GC)转介和接受情况的种族差异。

方法

对卡曼诺癌症研究所的 150 名乳腺癌患者的病历进行回顾,以根据国家综合癌症网络指南确定 GC 的资格、GC 转介率和预约完成率。使用逻辑回归评估人口统计学和临床因素与 GC 资格和转介的关系。

结果

诊断时的平均年龄为 57.1(SD 12.6),66%的女性为黑人。有 91 名女性(60.7%)有资格接受 GC,其中 54 名(61.4%)被转介。多变量分析后,与 GC 资格降低相关的因素包括诊断时年龄较大(OR=0.91,95%CI [0.87,0.95])和黑人种族(OR=0.37,95%CI [0.15,0.96])。在进一步的多变量分析后,GC 资格与增加转介的可能性相关(OR=5.97,95%CI [2.29,15.56]),然而,医疗保险与私人保险相比,转介的可能性较低(OR=0.32,95%CI [0.12-0.80])。在被转介的患者中,有 49 名(76.6%)完成了预约,有 47 名接受了基因检测。医疗保险的女性也不太可能完成预约。种族对转介或预约完成没有影响。

结论

在基于诊所的乳腺癌女性样本中,GC 转介或预约完成没有种族差异。需要进一步干预,以促进对有资格接受 GC 的乳腺癌女性增加转介和预约完成。